Impact of delays in radiotherapy of head and neck cancer on outcome
- PMID: 32819389
- PMCID: PMC7441656
- DOI: 10.1186/s13014-020-01645-w
Impact of delays in radiotherapy of head and neck cancer on outcome
Abstract
Background: In head and neck cancer (HNC), the relationship between a delay in starting radiotherapy (RT) and the outcome is unclear. The aim of the present study was to determine the impact of the amount of time before treatment intervention (TTI) and the growth kinetics of individual tumors on treatment outcomes and survival.
Methods: Two hundred sixty-two HNC patients with 273 primary tumors, treated with definitive (chemo) RT, were retrospectively analyzed. The TTI was defined as the time interval between the date of histopathologic diagnosis and the first day of the RT course. Volumetric data on 57 tumors were obtained from diagnostic and RT planning computer tomography (CT) scans in order to calculate the tumor growth kinetic parameters.
Results: No significant association between locoregional control or cause-specific hazards and TTI was found. The log hazard for locoregional recurrence linearly increased during the first 40 days of waiting for RT, although this was not significant. The median tumor volume relative increase rate and tumor volume doubling time was 3.2%/day and 19 days, respectively, and neither had any impact on locoregional control or cause-specific hazards.
Conclusion: The association between a delay in starting RT and the outcome is complex and does not harm all patients waiting for RT. Further research into imaging-derived kinetic data on individual tumors is warranted in order to identify patients at an increased risk of adverse outcomes due to a delay in starting RT.
Keywords: Head and neck cancer; Outcome; Radiotherapy; Treatment delay; Waiting time.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- World Health Organization . WHO life expectancy. 2018. Geneva: World Health Organization; 2019.
-
- Mackillop WJ, Zhou S, Groome P, Dixon P, Cummings BJ, Hayter C, et al. Changes in the use of radiotherapy in Ontario 1984-1995. Int J Radiat Oncol Biol Phys. 1999;44:355–362. - PubMed
-
- Miles EA, Clark CH, Urbano MT, Bidmead M, Dearnaley DP, Harrington KJ, et al. The impact of introducing intensity modulated radiotherapy into routine clinical practice. Radiother Oncol. 2005;77:241–246. - PubMed
-
- Grau C, Defourny N, Malicki J, Dunscombe P, Borras JM, Coffey M. Et al; on behalf of the HERO consortium. Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol. 2014;112:155–164. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical